This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of active pharmaceutical ingredients (APIs). Its structure is often exploited as a key intermediate in the creation of complex molecules, especially those targeting neurological and psychiatric disorders. It is commonly employed in the design of drugs that interact with specific receptors in the brain, such as serotonin or dopamine receptors, due to its pyrrolopyrazine scaffold, which is known for its bioactivity. Additionally, it is used in the development of potential treatments for conditions like depression, anxiety, and schizophrenia. Its hydrochloride form enhances solubility, making it more suitable for formulation and bioavailability studies in drug development processes.